eTrialTrackRTSM / IWRS designed around Delhi's clinical research ecosystem
Connect study teams, research sites and participants with practical manage randomization and trial supply workflows suited to the scale and complexity of clinical research in Delhi.
Clinical Research Context in Delhi
Delhi/NCR is one of India’s largest clinical-research markets. The source register snapshot lists 332 studies with New Delhi sites. AIIMS New Delhi operates a Clinical Research Unit and documents clinical-trial and translational-research activity. The source also identifies Sir Ganga Ram Hospital, Rajiv Gandhi Cancer Institute, Max Super Speciality Hospital, CIDP India and Tupalin Research as part of the research ecosystem. Clinical research activity changes over time, so this page uses a September 2026 snapshot as market context rather than a permanent study count.
The wider Delhi clinical-research ecosystem includes AIIMS New Delhi, Sir Ganga Ram Hospital, Rajiv Gandhi Cancer Institute, Max Super Speciality Hospital, CIDP India and Tupalin Research. These organizations are cited as examples of the local research environment and are not eTrialTrack customers unless a documented customer relationship exists.
How Can RTSM / IWRS Support Clinical Trials in Delhi?
For organizations operating in Delhi, the relevant technology question is not simply whether a digital platform is available, but whether it can support the operational requirements of the study. eTrialTrack RTSM / IWRS can be evaluated for workflows involving high-volume tertiary research, oncology and complex studies, participant tracking, electronic data capture and remote participant workflows. The product is designed to provide manage randomization and trial supply workflows through randomization, treatment assignment, eligibility rules, inventory, kit tracking and operational reporting. The exact configuration should be determined by protocol requirements, organizational procedures, user roles, integrations and implementation scope.
Why Consider eTrialTrack?
Organizations in Delhi can evaluate eTrialTrack RTSM / IWRS when they need a practical workflow that can be configured around their study rather than a generic process. Relevant product capabilities include Randomization; Treatment Assignment; Eligibility Rules; Inventory Management; Kit and Supply Tracking; Site-Level Access; Supply Status Visibility; Audit Trails and Reporting. Where appropriate, the module can connect with other eTrialTrack capabilities to create a more coherent participant, site and data workflow.
A Practical Local Implementation Approach
A typical discussion for a Delhi study can begin with study requirements, participant and site workflows, data responsibilities, user roles, integrations, implementation timelines and support expectations. From there, the relevant eTrialTrack capabilities can be configured and evaluated against the study requirements.
Local Research Ecosystem
AIIMS New Delhi, Sir Ganga Ram Hospital, Rajiv Gandhi Cancer Institute, Max Super Speciality Hospital, CIDP India and Tupalin Research. These names describe the broader market context only and should not be presented as customers, partners or users of eTrialTrack without documented evidence.
Important Scope
eTrialTrack RTSM / IWRS is a technology capability, not a substitute for the approved protocol, investigator responsibilities, ethics requirements, applicable regulations, quality procedures or clinical judgment. Product suitability should be assessed against the specific study and documented requirements.
Who uses eTrialTrack RTSM/IWRS in Delhi
For research teams in Delhi, the RTSM/IWRS module fits specific roles and study situations — here's who it serves, what it supports, and when to adopt it.
- Pharmaceutical companies and CROs operating in Delhi
- Investigator sites and hospitals across Delhi's research ecosystem
- Randomization and unblinded pharmacy teams
- Clinical supply managers tracking investigational product
- Dynamic randomization and treatment allocation
- IP supply, expiry and shipment tracking across depots and sites
- Automated resupply triggers and blinded kit management
- When adaptive or complex randomization designs outgrow manual lists
- When multi-depot supply chains need live stock visibility
- When you want local implementation support — onboarding and training aligned to IST, wherever your sites are
Interactive Web Response System in Delhi — frequently asked questions
What does the Interactive Web Response System do for Delhi clinical trials?
eTrialTrack RTSM/IWRS supports controlled randomization and trial supply workflows through a structured digital environment. The system can bring together treatment assignment, inventory visibility, site access, eligibility rules, kit tracking and relevant audit information.
Is the RTSM / IWRS module compliant for Delhi-based studies?
Yes — eTrialTrack is FDA 21 CFR Part 11, ICH-GCP, HIPAA and GDPR compliant, with complete audit trails and e-signatures accepted by Indian (CDSCO) and global regulators.
How quickly can our Delhi team deploy the Interactive Web Response System?
Most teams go live in 2-4 weeks, including configuration, validation support and team training in IST.
Can we get a Delhi demo of the RTSM / IWRS module?
Absolutely — book a 30-minute guided walkthrough and we will tailor it to your Delhi study setup and protocols.